Direct C7-functionalization of the pyrrolo[2,1-f][1,2,4]triazin-4-amine

- 342796
Abstract
Favorite this paper
How to cite this paper?
Abstract

The pyrrolo[2,1-f][1,2,4]triazin-4-amine scaffold is present in important contemporary pharmaceuticals, including remdesivir, the first FDA-approved antiviral drug for the treatment of COVID-19. Conventional synthetic approaches to remdesivir generally require pre-functionalization of the N-heterocycle under harsh reaction conditions.1 To date, only two reports have described the direct C7-functionalization of the pyrrolo[2,1-f][1,2,4]triazin-4-amine.2,3 In this context, we explored a new methodology employing functionalized 1,4-dihydropyridines (DHPs) as radical precursors for the generation of nucleophilic carbon-centered radicals, using (NH₄)₂S₂O₈ as the oxidant at 80 °C.4 Under these conditions, diethyl 4-(benzylcarbamoyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate afforded the corresponding C7-carbamoylated pyrrolotriazine in 70% isolated yield. Following optimization of the reaction conditions, a broad range of DHP derivatives, including sugar-substituted analogues, will be investigated to access novel C-nucleosides through direct C–H functionalization of the pyrrolotriazine core.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Federal University of São Carlos
  • 2 Universidade Federal de São Carlos | (Federal University of São Carlos)
Track
  • BMOS-2026
Keywords
N-heteroycles
C-glycosides
direct functionalization